Gene · 9261
Papers3,346
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,346
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CSF proteomic profiling with amyloid and tau pathology identifies distinctive sex-specific alteration of multiple proteins involved in Alzheimer's disease. | Alzheimers Dement | 2026 | 41505229 | PubTator, text mining | PubMed |
| Prognostic factors influencing outcomes of allogeneic HCT for AML with monosomal karyotype. | Int J Hematol | 2026 | 41493720 | PubTator, text mining | PubMed |
| From blood to heartbeat: Plasma proteins and Brugada syndrome revealed by Mendelian randomization. | Heart Rhythm | 2026 | 41067469 | PubTator, text mining | PubMed |
| A housekeeping gene search to analyze expression changes of individual genes in Macaca mulatta. | Vavilovskii Zhurnal Genet Selektsii | 2025 | 41660605 | PubTator, text mining | PubMed |
| Targeted degradation of MK2 is insufficient to block inflammatory cytokine production in human cells due to cooperativity with MK3 and MK5. | Front Immunol | 2025 | 41613108 | PubTator, text mining | PubMed |
| Chemotherapy-induced adipo-lineage cell senescence drives bone loss. | Nat Commun | 2025 | 41469373 | PubTator, text mining | PubMed |
| Non-Catalytic Inhibitors of the p38/MK2 Interface: Repurposing Approved Drugs to Target Neuroinflammation in Alzheimer's Disease. | J Med Chem | 2025 | 41348991 | PubTator, text mining | PubMed |
| iRGD-modified co-loaded curcumin piperine liposomes inhibit angiogenesis in non-small cell lung cancer through the VEGFR2/P38/MK2 signaling axis. | Discov Oncol | 2025 | 41201753 | PubTator, text mining | PubMed |
| Dissecting stress-activated protein kinase (SAPK)-signaling pathways using multiplex gene knockout HeLa cells. | J Biol Chem | 2025 | 41197724 | PubTator, text mining | PubMed |
| CRISPR-Induced Mutations of mk2b and mk3 Host Proteins Enhance Chikungunya Virus Susceptibility and Modulate Host Immune Responses in Zebrafish. | FASEB J | 2025 | 41117602 | PubTator, text mining | PubMed |
| Novel therapies for axial spondyloarthritis and future directions. | Best Pract Res Clin Rheumatol | 2025 | 41073187 | PubTator, text mining | PubMed |
| MK2-mediated AKT/MYC signaling activation promotes epithelial-mesenchymal transition in lung adenocarcinoma. | Front Genet | 2025 | 41070228 | PubTator, text mining | PubMed |
| Evaluation of the anti-leukemia activity and underlying mechanisms of the novel perinucleolar compartment inhibitor CTI-2 in acute myeloid leukemia. | Invest New Drugs | 2025 | 41032175 | PubTator, text mining | PubMed |
| Decoding the Molecular Landscape of Inflammatory Bowel Disease: A Mendelian Randomization and Machine Learning Analysis. | J Gastroenterol Hepatol | 2025 | 41030199 | PubTator, text mining | PubMed |
| Measuring the Senescence-Associated Secretory Phenotype. | Biomedicines | 2025 | 41007626 | PubTator, text mining | PubMed |
| Beneficial Handling of Molecular Chaperones (Chaperonotherapy) in Glioblastoma and Neuroblastoma: Novel Therapeutic Targets or Potential Agents? | Cells | 2025 | 41002413 | PubTator, text mining | PubMed |
| Ubiquitination-activated TAB-TAK1-IKK-NF-κB axis modulates gene expression for cell survival in the lysosomal damage response. | Elife | 2025 | 40990917 | PubTator, text mining | PubMed |
| Genomic discovery of EF-24 targets unveils antitumorigenic mechanisms in leukemia cells. | PLoS One | 2025 | 40986633 | PubTator, text mining | PubMed |
| Desmoglein-driven dynamic signaling in pemphigus vulgaris: a systematic review of pathogenic pathways. | NPJ Regen Med | 2025 | 40846710 | PubTator, text mining | PubMed |
| Oncogenic Mechanisms of Kaposi's Sarcoma-Associated Herpesvirus on Cell Metabolism and Cell Transformation. | J Med Virol | 2025 | 40827105 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9261/papers?page=3